Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Urology|January 24, 2019
Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: clinical evidence and experienceKarin Purshouse, Andrew S Protheroe
Cancer Treatment Reviews|May 18, 2004
Systemic chemotherapy for patients with bladder cancer--current controversies and future directionsJohn D Chester, Geoffrey D Hall, Martin Forster, et al.
Plos One|February 2, 2018
RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibitionPhilip Earwaker, Caroline Anderson, Frances Willenbrock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
The type 1 insulin-like growth factor receptor pathwayMeenali M Chitnis, John S P Yuen, Andrew S Protheroe, et al.
Molecular Cancer Therapeutics|June 11, 2009
Validation of the type 1 insulin-like growth factor receptor as a therapeutic target in renal cancerJohn S P Yuen, Erdem Akkaya, Yong Wang, et al.
Cancer Research|August 17, 2010
Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cellsTamara Aleksic, Meenali M Chitnis, Olga V Perestenko, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 4, 2012
Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaksBenjamin W Turney, Martin Kerr, Meenali M Chitnis, et al.
British Journal of Cancer|October 26, 2018
Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UKRobert A Watson, Hugo De La Peña, Maria T Tsakok, et al.
Clinical Genitourinary Cancer|January 17, 2018
Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional CenterHelen E J Tyrrell, David N Church, Johnson Joseph, et al.
BJUI Compass|April 7, 2023
PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancerVictoria K Woodcock, Ji-Li Chen, Karin Purshouse, et al.
Pageof 2